Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Progenics Pharmaceuticals Inc. (PGNX)’

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Market Movers Today: Dropbox, Inc. (DBX), Micron Technology, Inc. (MU), New York & Company, Inc. (NWY), Geron Corporation (GERN), and More

Dropbox, Inc. (NASDAQ:DBX) (Reuters) (Reuters) – Dropbox Inc’s shares soared by as much as 50 percent in their first day of trading on Friday......(read more)

March 23 - Market Movers, News - Comments

Portfolio Cuts Couldn’t Stop HealthInvest From Buying Up These Stocks

HealthInvest Partners AB is a Stockholm-based fund management company co-founded by Carl Bennet and Anders Hallberg in 2006, which specializes in the......(read more)

October 29 - ETF Trading, Hedge Funds, News - Comments

Valeant VRX contact lenses women finger eye care vision medical

Biotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant Pharmaceuticals Intl Inc (VRX) Progenics Pharmaceuticals, Inc. (PGNX)

Last week, the FDA had two major decisions to make regarding troubled drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The first was whether or......(read more)

July 29 - News, Stock Analysis - Comments

stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

Why Valeant, Progenics, Ryerson, Zafgen and TerraForm Are On The Move Today

U.S stocks headed back into the green on Wednesday, helped by strong earnings reports from the tech sector and a rebound in oil prices, driven by a slightly......(read more)

July 20 - Market Movers, News - Comments

Most Affordable Chemical Engineering Schools in The US

Here’s Why These Five Stocks Are Trending

It’s been a quiet day on Wall Street so far, as the three major index futures haven’t deviated much from yesterday’s close. However,......(read more)

June 21 - Market Movers, News - Comments

Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside

To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......(read more)

April 16 - Hedge Funds, News - Comments

Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains

Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).......(read more)

March 25 - Hedge Funds, News - Comments

Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)

Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’......(read more)

July 22 - Hedge Funds, News - Comments

Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a good investment? To the average investor, there are tons of indicators shareholders can use to watch......(read more)

September 17 - News - Comments

Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

Is it smart to be bullish on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? At the moment, there are tons of metrics shareholders can use to monitor their......(read more)

September 12 - News - Comments

Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

Is it smart to be bullish on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? At the moment, there are tons of methods market participants can use to watch......(read more)

September 3 - News - Comments

Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week

With August winding down, summer won’t be around much longer. Several health-care stocks still had hot days this past week, though. Here are three......(read more)

September 1 - News - Comments